Curcumin / Turmeric

September 2019

Which is the Best Curcumin Supplement?

Check out our unbiased recommendation of the best products on the market using our rigorous methodology. We screen products for the right formulation, bioavailability, safety, and efficacy to bring you only the best supplements available in 2019.

Briefly about Curcumin

Curcumin is produced from the spice turmeric, and numerous clinical studies have shown that it has many proven and promising health benefits. In particular, studies show that curcumin acts as an antioxidant. It also has been shown to act as an anti-inflammatory in humans, although more studies are needed to demonstrate that curcumin is effective in treating chronic inflammatory conditions like rheumatoid arthritis. Curcumin also may help prevent certain types of cancer and reverse symptoms of Alzheimer’s disease.

Curcumin is not very bioavailable in its natural form. However, it can be taken as a supplement, several of which have been specially formulated for increased bioavailability and absorption. Some manufacturers add black pepper extracts like piperine to achieve this effect. However, this is an irritant for some people. Phospholipid addition (as in the Meriva formulation) has been shown to be more effective and non-irritating.

When choosing a curcumin supplement, remember the following:

  • Check the concentration on the label – you want to maximize the amount of active curcuminoids per serving
  • Look for products in the Meriva or Theracurmin formulation as these have been specially developed to measurably increase concentration and bioavailability of curcumin and have been used in research trials
  • Choose a product that contains phospholipids to increase absorption
  • Take your curcumin supplement with a meal that contains fat for better absorption
  • Select a high-quality brand in order to avoid impurities, toxins, and fillers
  • You will likely want to consumer 500mg or more per day to make an impact
  • Check with your doctor about potential negative drug interactions, if you’re taking any

A Closer Look at Curcumin

Curcumin is a compound derived from turmeric, a spice that comes from the roots of a tropical plant called the Curcuma longa. Curcumin is thought to be the most biologically active part of turmeric and has been used in traditional Chinese and East Indian medicine for more than four millennia to reduce inflammation, aid digestion, treat wounds, and alleviate skin conditions. Some countries and regions – particularly India, Southeast Asia, and the Middle East – also use it for cooking. For example, the taste and yellow color of curry, along with the color of some mustards and cheeses, come from curcumin.[1, 2]

There are a number of studies showing that curcurmin has anti-inflammatory, anti-oxidant, anticancer, and other beneficial properties. Generally speaking, curcumin’s benefits come from regulating transcription factors, inflammatory cytokines, protein kinases, and other molecular targets in various ways.[3] However, some studies purporting to show health effects are inconclusive because they were relatively small and/or involved animals instead of humans. The following is a summary of some of the current research.

Antioxidant functions

Curcumin has been found to react in test tubes with chemicals that contain oxygen and nitrogen.[4, 5] However, researchers are still uncertain whether this effect takes place the same way in living organisms, in part because of curcumin’s relatively low bioavailability (see below). However, some studies have found that it does have direct antioxidant effects in the intestines and can also cause various antioxidant enzymes such as glutamate-cysteine ligase to be expressed in the body, which promote critical chemical reactions.[6, 7, 8] Other studies indicate that curcumin has antioxidant effects in rats.[9] And in a study specifically targeted at healthy people — as opposed to those with preexisting health conditions, which served as the subjects for some other curcumin studies on humans — researchers found that curcumin raised the ability of compounds in saliva to scavenge free radicals, and also raised the levels of the plasma antioxidant enzyme catalase.[10]

Anti-inflammatory functions

Curcumin also has been found to have properties that reduce inflammation by inhibiting various enzymes and molecular pathways involved in the body’s inflammatory response.[12] For example, in one study researchers found that a particular formulation of curcumin called Meriva, in combination with other treatments, might be an effective way to manage or even treat osteoarthritis in humans because of curcumin’s anti-inflammatory properties.[11, 16] Other studies found that curcumin had a therapeutic effect in mice with ulcerative colitis and arthritis.[13, 14, 15] Researchers have found that curcumin can help reduce inflammation following surgery and a traumatic brain injury.[16] Because of its ability to reduce inflammation, curcumin has been found to have positive effects in patients with a host of other inflammatory diseases such as uveitis, ulcerative proctitis, Crohn’s disease, tropical pancreatitis, peptic and gastric ulcers, and lupus.[59]

Cancer

Cucumin administered orally has been found to help prevent oral, stomach, colon, and liver cancer that was chemically induced in mice.[17, 18, 19, 20, 21, 22, 23, 24] Although so far there is little clinical evidence that curcumin prevents cancer in humans, one study found that it has “enormous” potential to suppress tumor growth and the spread of cancer to other parts of the body.[25] In addition, it has been found to interact with the same molecular targets that cancer drugs target.[26] This means that curcumin has the potential to make chemotherapy and other cancer drugs more effective, although more studies are needed to confirm this effect.[27, 28]

Type 2 Diabetes

Some studies indicate that curcumin could help prevent and treat type 2 diabetes because of its ability to fight inflammation and lower blood sugar.[29] For example, one nine-month study found that curcumin reduced the number of prediabetic subjects who ultimately developed diabetes.[30] Another found that it reduced inflammation and signs of oxidative stress in people with diabetes, although it did not lower blood glucose levels.[31] Additional research determined that curcumin improved insulin sensitivity.[32]

Alzheimer’s

Curcumin has been found to decrease concentrations of amyloid proteins in the the brains of animals, which could help slow the progression of Alzheimer’s disease. However, studies still need to be conducted to see if this effect holds for humans, and it should be noted that the percentage decrease in amyloid proteins was not large.[33] Additional studies have produced similar results, but they also were conducted in animals or on cells in test tubes, and frequently used concentrations of curcumin that would be impractical for humans to consume.[34, 35, 36] In addition, most phase III clinical trials conducted to see whether curcumin can treat Alzheimer’s have not been successful.[37] As a result, the effectiveness of curcumin as a treatment for the disease remains an open question.

Depression

An analysis of six randomized controlled trials found that people suffering from clinical depression who took curcumin supplements saw their symptoms decrease. The greatest effects were found after people took curcumin for at least four weeks.[38] Additional studies have found that curcumin either had the same positive effects on symptoms as depression medications or enhanced the effects of those medications.[40, 41] The science is mixed, however, because another study found no effect from curcumin on symptoms of depression in subjects who were already taking medication for it.[39] Thus, as with Alzheimer’s, more research is needed to determine whether curcumin is an effective treatment of depression.

Irritable Bowel Syndrome/Inflammatory Bowel Disease

Curcumin, when taken in combination with fennel essential oil, also has been found to reduce abdominal pain and other symptoms of IBS in both humans and rats.[54, 55] In addition, curcumin has been shown to relieve the symptoms of IBD due to its anti-inflammatory effects.[56, 57, 58]

Pain

Curcumin has shown some promise as a pain reliever. For example, One of the primary positive effects of curcumin on many inflammatory conditions is to relieve the pain associated with them.[60, 64] Another small study found that a particular formulation of curcumin called Meriva has the potential to relieve pain associated with high-impact sports, and it was found to relieve neuropathic pain in rats.[61, 62, 63] Finally, it has been shown to control postoperative pain and pain from burns.[65, 66]

Other conditions

Additional research indicates that curcumin might help people with reproductive problems caused by stress, such as male infertility.[49] Preliminary research also indicates that it has the potential to help treat autoimmune disorders, although additional studies are needed to see whether this is true.[50] And curcumin also might help improve HDL cholesterol and metabolism of lipids.[51]

Supplementing with Curcumin

Turmeric only contains about 2-9 percent curcimunoids, of which curcumin is the most prevalent (the other curcimunoids are demethoxycurcumin and bisdemethoxycurcumin).[42] On top of this, curcumin has low bioavailability because it is both poorly absorbed and quickly metabolised. However, it has been shown to be safe in high doses up to 12 grams per day.[43, 44] Even a diet containing a large amount of tumeric will only provide around 60-100 mg of curcumin per day. By contrast, in most studies showing therapeutic effects of curcumin for various conditions, the subjects consumed at least 500 mg per day. As a result, food alone is unlikely to provide enough curcumin to provide measurable health effects, and thus supplementation is needed.

Several formulations of curcumin supplements have been developed in an attempt to improve the bioavailability of curcumin. For example, a formulation called Theracurmin that includes nanoparticles of curcumin was found to increase blood concentrations of the compound.[45] Another formulation that combined curcumin with a hydrophilic carrier, derivatives of cellulose, and antioxidants also significantly increased bioavailability compared to a standard curcumin supplement.[46] Eating black pepper along with curcumin has been shown to increase bioavailability as well.[47] As a result, one company (the Sabinsa Corporation) has developed a curcumin supplement that contains Bioperine, a type of black pepper extract. And, as with most nutrients that dissolve in fat, consuming fat with curcumin also will help the body use curcumin more effectively.

When choosing a curcuramin supplement, always select a high-quality brand in order to avoid supplements contaminated by impurities or toxins. Curcuramin supplemnents sold in stores usually also contain emethoxycurcumin and bisdemethoxycurcumin. Many of the labels claim to contain 95 percent curcuminoids, although this claim (as will most claims about supplements) is not regulated by the U.S. Food and Drug Administration.

Proper Dosage and Contraindications

Be sure to eat something when you take a curcumin supplement to avoid stomach upset.[48] Curcumin has been found to be safe at up to 12 grams per day.[52]

Curcumin may increase the effects of blood-thinning medications like warfarin (Coumadin), clopidogrel (Plavix), and aspirin, which could raise the risk of excessive bleeding. It also might keep stomach acid-reducing drugs like cimetidine (Tagamet), famotidine (Pepcid), and ranitidine (Zantac), from working properly; and increase the effects of diabetes drugs, which could result in excessively low blood sugar. Finally, because of curcumin’s anti-inflammatory effects, it could have negative interactions with with non-steroidal anti-inflammatory drugs. Anyone taking any of these medications should consult a doctor before consuming curcumin.[53]

Which is the Best Curcumin Supplement?

Check out our unbiased recommendation of the best products on the market using our rigorous methodology. We screen products for the right formulation, bioavailability, safety, and efficacy to bring you only the best supplements available in 2019.

References:
1 “Turmeric.” University of Maryland Medical Center. January 2017. Accessed through: https://www.umm.edu/health/medical/altmed/herb/turmeric
2 Gupta SC, Kismali G, Aggarwal BB. “Curcumin, a component of turmeric: from farm to pharmacy.” Biofactors. 2013 Jan-Feb;39(1):2-13. doi: 10.1002/biof.1079. Epub 2013 Jan 22. Review. PubMed PMID: 23339055. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/23339055
3 Zhou H, Beevers CS, Huang S. “The targets of curcumin.” Curr Drug Targets. 2011 Mar 1;12(3):332-47. Review. PubMed PMID: 20955148; PubMed Central PMCID: PMC3025067. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/20955148
4 Sreejayan, Rao MN. “Nitric oxide scavenging by curcuminoids.” J Pharm Pharmacol. 1997 Jan;49(1):105-7. PubMed PMID: 9120760. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/9120760
5 Sreejayan N, Rao MN. “Free radical scavenging activity of curcuminoids.” Arzneimittelforschung. 1996 Feb;46(2):169-71. PubMed PMID: 8720307. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/8720307
6 Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ, Berry DP. “Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration.” Br J Cancer. 2004 Mar 8;90(5):1011-5. PubMed PMID: 14997198; PubMed Central PMCID: PMC2409622. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/14997198
7 Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. “Dose escalation of a curcuminoid formulation.” BMC Complement Altern Med. 2006 Mar 17;6:10. PubMed PMID: 16545122; PubMed Central PMCID: PMC1434783. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/16545122
8 Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.” Anticancer Res. 2001 Jul-Aug;21(4B):2895-900. PubMed PMID: 11712783. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/11712783
9 Bulmuş FG, Sakin F, Türk G, Sönmez M, Servi K. “Protective effects of curcumin on antioxidant status, body weight gain, and reproductive parameters in male rats exposed to subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin.” Toxicological & Environmental Chemistry. 2013;95(6):1019-1029. DOI: https://doi.org/10.1080/02772248.2013.829061. Accessed through: http://www.tandfonline.com/doi/abs/10.1080/02772248.2013.829061#.UyAZAfl_t8E
10 DiSilvestro RA, Joseph E, Zhao S, Bomser J. “Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people.” Nutr J. 2012; 11: 79. doi: 10.1186/1475-2891-11-79. Accessed through: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518252/
11 Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. “Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.” Altern Med Rev. 2010 Dec;15(4):337-44. PubMed PMID: 21194249. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/21194249
12 Ghosh S, Banerjee S, Sil PC. “The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.” Food Chem Toxicol. 2015 Sep;83:111-24. doi: 10.1016/j.fct.2015.05.022. Epub 2015 Jun 9. Review. PubMed PMID: 26066364. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/26066364
13 Li CP, Li JH, He SY, Chen O, Shi L. “Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis.” Genet Mol Res. 2015 Apr 15;14(2):3450-8. doi: 10.4238/2015.April.15.8. PubMed PMID: 25966111. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/25966111
14 Yang JY, Zhong X, Yum HW, Lee HJ, Kundu JK, Na HK, Surh YJ. “Curcumin Inhibits STAT3 Signaling in the Colon of Dextran Sulfate Sodium-treated Mice.” J Cancer Prev. 2013 Jun;18(2):186-91. PubMed PMID: 25337545; PubMed Central PMCID: PMC4189454. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/25337545
15 Moon DO, Kim MO, Choi YH, Park YM, Kim GY. “Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.” Int Immunopharmacol. 2010 May;10(5):605-10. Doi: 10.1016/j.intimp.2010.02.011. Epub 2010 Feb 23. PubMed PMID: 20188213. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/20188213
16 Zhu HT, Bian C, Yuan JC, Chu WH, Xiang X, Chen F, Wang CS, Feng H, Lin JK. “Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury.” J Neuroinflammation. 2014 Mar 27;11:59. doi: 10.1186/1742-2094-11-59. PubMed PMID: 24669820; PubMed Central PMCID: PMC3986937. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/24669820
17 Krishnaswamy K, Goud VK, Sesikeran B, Mukundan MA, Krishna TP. “Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin.” Nutr Cancer. 1998;30(2):163-6. PubMed PMID: 9589436. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/9589436
18 Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Han C, Chen J, Huang MT, Yang CS. “Inhibition of 7,12-dimethylbenz[a]anthracene-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002 Aug;23(8):1307-13. PubMed PMID: 12151348. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/12151348
19 Ikezaki S, Nishikawa A, Furukawa F, Kudo K, Nakamura H, Tamura K, Mori H. “Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine and sodium chloride in rats.” Anticancer Res. 2001 Sep-Oct;21(5):3407-11. PubMed PMID: 11848501. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/11848501
20 Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. “Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.” Cancer Res. 1994 Nov 15;54(22):5841-7. PubMed PMID: 7954412. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/7954412
21 Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL. “Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.” Carcinogenesis. 2000 Feb;21(2):331-5. PubMed PMID: 10657978. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/10657978
22 Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA. “Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.” Carcinogenesis. 1996 Jun;17(6):1305-11. PubMed PMID: 8681447. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/8681447
23 Rao CV, Rivenson A, Simi B, Reddy BS. “Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.” Cancer Res. 1995 Jan 15;55(2):259-66. PubMed PMID: 7812955. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/7812955
24 Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. “Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.” Cancer Res. 1999 Feb 1;59(3):597-601. PubMed PMID: 9973206. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/9973206
25 Aggarwal BB, Kumar A, Bharti AC. “Anticancer potential of curcumin: preclinical and clinical studies.” Anticancer Res. 2003 Jan-Feb;23(1A):363-98. Review. PubMed PMID: 12680238. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/12680238
26 Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. “Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.” Clin Sci (Lond). 2017 Jul 5;131(15):1781-1799. doi: 10.1042/CS20160935. Print 2017 Aug 1. Review. PubMed PMID: 28679846. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28679846
27 Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G. “Curcumin and gemcitabine in patients with advanced pancreatic cancer.” Nutr Cancer. 2010;62(8):1137-41. doi: 10.1080/01635581.2010.513802. PubMed PMID: 21058202. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/21058202
28 Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, Mouret-Reynier MA, Durando X, Barthomeuf C, Chollet P. “Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer.” Cancer Biol Ther. 2010 Jan;9(1):8-14. Epub 2010 Jan 21. PubMed PMID: 19901561. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/19901561
29 Rivera-Mancía S, Lozada-García MC, Pedraza-Chaverri J. “Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications.” Eur J Pharmacol. 2015 Jun 5;756:30-7. Doi: 10.1016/j.ejphar.2015.02.045. Epub 2015 Mar 10. Review. PubMed PMID: 25769841. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/25769841
30 Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. “Curcumin extract for prevention of type 2 diabetes.” Diabetes Care. 2012 Nov;35(11):2121-7. doi: 10.2337/dc12-0116. Epub 2012 Jul 6. PubMed PMID: 22773702; PubMed Central PMCID: PMC3476912. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/22773702
31 Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N. “Effect of NCB-02 and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.” Drugs R D. 2008;9(4):243-50. PubMed PMID: 18588355. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/18588355
32 Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. “Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial.” J Nutr Biochem. 2014 Feb;25(2):144-50. doi: 10.1016/j.jnutbio.2013.09.013. Epub 2013 Nov 6. PubMed PMID: 24445038. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/24445038
33 DiSilvestro RA, Joseph E, Zhao S, Bomser J. “Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people.” Nutr J. 2012;11:79. doi: 10.1186/1475-2891-11-79. Accessed through: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518252
34 Lin R, Chen X, Li W, Han Y, Liu P, Pi R. “Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin.” Neurosci Lett. 2008 Aug 8;440(3):344-7. doi: 10.1016/j.neulet.2008.05.070. Epub 2008 May 24. PubMed PMID: 18583042. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/18583042
35 Zhang C, Browne A, Child D, Tanzi RE. “Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein.” J Biol Chem. 2010 Sep 10;285(37):28472-80. doi: 10.1074/jbc.M110.133520. Epub 2010 Jul 9. PubMed PMID: 20622013; PubMed Central PMCID: PMC2937872. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/20622013
36 Shi X, Zheng Z, Li J, Xiao Z, Qi W, Zhang A, Wu Q, Fang Y. “Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: Involvement of ERK1/2 and p38 signaling pathways.” Neurosci Lett. 2015 May 6;594:105-10. Doi: 10.1016/j.neulet.2015.03.045. Epub 2015 Mar 25. PubMed PMID: 25818332. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/25818332
37 Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, Martins RN. “Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease.” Br J Nutr. 2016 Feb 14;115(3):449-65. Doi: 10.1017/S0007114515004687. Epub 2015 Dec 14. Review. PubMed PMID: 26652155. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/26652155
38 Al-Karawi D, Al Mamoori DA, Tayyar Y. “The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials.” Phytother Res. 2016 Feb;30(2):175-83. doi: 10.1002/ptr.5524. Epub 2015 Nov 27. Review. PubMed PMID: 26610378. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/26610378
39 Bergman J, Miodownik C, Bersudsky Y, Sokolik S, Lerner PP, Kreinin A, Polakiewicz J, Lerner V. “Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study.” Clin Neuropharmacol. 2013 May-Jun;36(3):73-7. doi: 10.1097/WNF.0b013e31828ef969. PubMed PMID: 23673908. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/23673908
40 Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB. “Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial.” Phytother Res. 2014 Apr;28(4):579-85. Doi: 10.1002/ptr.5025. Epub 2013 Jul 6. PubMed PMID: 23832433. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/23832433
41 Yu JJ, Pei LB, Zhang Y, Wen ZY, Yang JL. “Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.” J Clin Psychopharmacol. 2015 Aug;35(4):406-10. doi: 10.1097/JCP.0000000000000352. PubMed PMID: 26066335. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/26066335
42 Lechtenberg M, Quandt B, Nahrstedt A. “Quantitative determination of curcuminoids in Curcuma rhizomes and rapid differentiation of Curcuma domestica Val. and Curcuma xanthorrhiza Roxb. by capillary electrophoresis.” Phytochem Anal. 2004 May-Jun;15(3):152-8. PubMed PMID: 15202598. Accessed through: http://www.ncbi.nlm.nih.gov/pubmed/15202598
43 Sharma RA, Gescher AJ, Steward WP. “Curcumin: the story so far.” Eur J Cancer. 2005 Sep;41(13):1955-68. Review. PubMed PMID: 16081279. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/16081279
44 Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. “Bioavailability of curcumin: problems and promises. Mol Pharm. 2007 Nov-Dec;4(6):807-18. Epub 2007 Nov 14. Review. PubMed PMID: 17999464. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/17999464
45 Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T. “Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy
human volunteers.” Cancer Chemother Pharmacol. 2012 Jan;69(1):65-70. Doi: 10.1007/s00280-011-1673-1. Epub 2011 May 21. PubMed PMID: 21603867. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/21603867
46 Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. “Comparative absorption of curcumin formulations.” Nutr J. 2014 Jan 24;13:11. Doi: 10.1186/1475-2891-13-11. PubMed PMID: 24461029; PubMed Central PMCID: PMC3918227. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/24461029
47 Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.” Planta Med. 1998 May;64(4):353-6. PubMed PMID: 9619120. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/9619120
48 Hendler SS, Rorvik DM. “PDR for Nutritional Supplements.” 2nd ed: Thomson Reuters; 2008.
49 Mohamadpour M, Noorafshan A, Karbalay-Doust S, Talaei-Khozani T, Aliabadi E. “Protective effects of curcumin co-treatment in rats with establishing chronic variable stress on testis and reproductive hormones.” Int J Reprod Biomed (Yazd). 2017 Jul;15(7):447-452. PubMed PMID: 29177247; PubMed Central PMCID: PMC5601937. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/29177247
50 Jagetia GC, Aggarwal BB. “”Spicing up” of the immune system by curcumin.” J Clin Immunol. 2007 Jan;27(1):19-35. Epub 2007 Jan 9. Review. PubMed PMID: 17211725. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/17211725
51 Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M, Sahebkar A. “Effects of curcumin on HDL functionality. Pharmacol Res. 2017 May;119:208-218. Doi: 10.1016/j.phrs.2017.02.008. Epub 2017 Feb 10. Review. PubMed PMID: 28192240. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28192240
52 Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. “Dose escalation of a curcuminoid formulation.” BMC Complement Altern Med. 2006 Mar 17;6:10. PubMed PMID: 16545122; PubMed Central PMCID: PMC1434783. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/16545122
53 “Possible Interactions with: Turmeric.” University of Maryland Medical Center. January 2015.
Accessed through: https://www.umm.edu/health/medical/altmed/herb-interaction/possible-interactions-with-turmeric
54 Portincasa P, Bonfrate L, Scribano ML, Kohn A, Caporaso N, Festi D, Campanale MC, Di Rienzo T, Guarino M, Taddia M, Fogli MV, Grimaldi M, Gasbarrini A. “Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.” J Gastrointestin Liver Dis. 2016 Jun;25(2):151-7. Doi: 10.15403/jgld.2014.1121.252.ccm. PubMed PMID: 27308645. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/27308645
55 Yu Y, Wu S, Li J, Wang R, Xie X, Yu X, Pan J, Xu Y, Zheng L. “The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.” Metab Brain Dis. 2015 Feb;30(1):47-55. doi: 10.1007/s11011-014-9554-z. Epub 2014 May 8. PubMed PMID: 24807589. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/24807589
56 Gopi S, Amalraj A, Jude S, Varma K, Sreeraj TR, Haponiuk JT, Thomas S. “Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber.” Mater Sci Eng C Mater Biol Appl. 2017 Dec 1;81:20-31. doi: 10.1016/j.msec.2017.07.037. Epub 2017 Jul 24. PubMed PMID: 28887965. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28887965
57 Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. “Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2017 Aug 11:1-13. doi: 10.1080/10408398.2017.1358139. [Epub ahead of print] PubMed PMID: 28799796. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28799796
58 Fadus MC, Lau C, Bikhchandani J, Lynch HT. “Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.” J Tradit Complement Med. 2016 Sep 9;7(3):339-346. doi: 10.1016/j.jtcme.2016.08.002. eCollection 2017 Jul. Review. PubMed PMID: 28725630; PubMed Central PMCID: PMC5506636. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28725630
59 Gupta SC, Patchva S, Aggarwal BB. “Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials.” AAPS J. 2013 Jan;15(1):195–218. Doi: 10.1208/s12248-012-9432-8. Accessed through: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535097
60 El Nebrisi EG, Bagdas D, Toma W, Al Samri H, Brodzik A, Alkhlaif Y, Yang KS, Howarth FC, Damaj IM, Oz M. “Curcumin acts as a positive allosteric modulator of α7-nicotinic acetylcholine receptors and reverses nociception in mouse models of inflammatory pain.” J Pharmacol Exp Ther. 2018 Jan 16. pii: jpet.117.245068. Doi: 10.1124/jpet.117.245068. [Epub ahead of print] PubMed PMID: 29339457. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/29339457
61 Di Pierro F, Zacconi P, Bertuccioli A, Togni S, Eggenhoffner R, Giacomelli L, Scaltrini S. “A naturally-inspired, curcumin-based lecithin formulation (Meriva® formulated as the finished product Algocur®) alleviates the osteo-muscular pain conditions in rugby players.” Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4935-4940. PubMed PMID: 29164565. https://www.ncbi.nlm.nih.gov/pubmed/29164565
62 Zhao S, Yang J, Han X, Gong Y, Rao S, Wu B, Yi Z, Zou L, Jia T, Li L, Yuan H, Shi L, Zhang C, Gao Y, Li G, Liu S, Xu H, Liu H, Liang S. “Effects of nanoparticle-encapsulated curcumin on HIV-gp120-associated neuropathic pain induced by the P2X(3) receptor in dorsal root ganglia.” Brain Res Bull. 2017 Oct;135:53-61. Doi: 10.1016/j.brainresbull.2017.09.011. Epub 2017 Sep 28. PubMed PMID: 28962965. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28962965
63 Ceyhan D, Kocman AE, Yildirim E, Ozatik O, Aydin S, Aydan K. “Comparison of the effects of curcumin, tramadol and surgical treatments on neuropathic pain induced by chronic constriction injury in rat.” Turk Neurosurg. 2017 Apr 4. Doi: 10.5137/1019-5149.JTN.19824-17.0. [Epub ahead of print] PubMed PMID: 28481389. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/28481389
64 Zhang Z, Leong DJ, Xu L, He Z, Wang A, Navati M, Kim SJ, Hirsh DM, Hardin JA, Cobelli NJ, Friedman JM, Sun HB. “Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model.” Arthritis Res Ther. 2016 Jun 3;18(1):128. Doi: 10.1186/s13075-016-1025-y. PubMed PMID: 27260322; PubMed Central PMCID: PMC4891896. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/27260322
65 Cheppudira B, Fowler M, McGhee L, Greer A, Mares A, Petz L, Devore D, Loyd DR, Clifford JL. “Curcumin: a novel therapeutic for burn pain and wound healing.” Expert Opin Investig Drugs. 2013 Oct;22(10):1295-303. Doi: 10.1517/13543784.2013.825249. Epub 2013 Aug 1. Review. PubMed PMID: 23902423. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/23902423
66 Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. “Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a
double-blind, randomized placebo-controlled study.” Surg Endosc. 2011 Dec;25(12):3805-10. doi: 10.1007/s00464-011-1793-z. Epub 2011 Jun 14. PubMed PMID: 21671126. Accessed through: https://www.ncbi.nlm.nih.gov/pubmed/21671126